NCT05312853View on ClinicalTrials.gov

Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

April 15, 2034

Study Completion Date

December 31, 2034

Conditions
Chronic Liver Disease
Trial Locations (1)

55131

University Medical Center of the Johannes Gutenber Univeristy, Mainz

Sponsors
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Nordic Bioscience A/S

INDUSTRY

lead

Johannes Gutenberg University Mainz

OTHER

NCT05312853 - Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease. | Biotech Hunter | Biotech Hunter